Advertisement
Advertisement
ALNY
Alnylam Pharmaceuticals, Inc.
231.83
USDSponsored
-2.20
-0.94%
Oct 16, 15:59 UTC -4
Closed
After-Market
231.93
+0.09
+0.04%
Alnylam Pharmaceuticals, Inc. Financial Snapshot
| Market Cap | 31.03B |
| Beta | 0.28 |
| Earnings Per Share (EPS) | 5.38 |
| Price-to-Book (P/B) Ratio | 23.13 |
| Operating Margin | 15.26% |
| Total Debt/Equity (D/E) | 74.66% |
| P/E Ratio | 43.50 |
| Return on Equity (ROE) | 84.93% |
| Current Ratio | 3.05% |
| Free Cash Flow | 340.71M |